Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 5, 2000, Pages 497-500

  Picton, Michael L ^a   Foley, Robert N ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMORBIDITY; DIALYSIS; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MORTALITY; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK FACTORS;

EID: 0033855090     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200009000-00006     Document Type: Review

References (26)

1. United States Renal Data System. 1999 Annual Data Report
2. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure
3. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure
4. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
5. Incidence of atherosclerotic arterial occlusive accidents in pre-dialysis and dialysis patients: A multicentric study in the Ile de France district
6. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
7. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
8. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
9. Acute myocardial infarction in patients with end-stage renal disease
10. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients
11. Sudden and cardiac death rates in hemodialysis patients
12. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
13. 'U' curve association of blood pressure and mortality in hemodialysis patients
14. Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions
15. Alterations of arterial function in end-stage renal disease
16. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group
17. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease
18. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
19. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
20. Achievement and safety of a low blood pressure goal in chronic renal disease
21. Survival of patients with renovascular disease and ACE inhibition
22. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialysed uremics independently from hypotensive effects
23. Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy
24. Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease. Comparative effects of ACE-inhibition and calcium channel blockade